Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Weichselbaum

Showing results (711-720 of 727) with videos related to

Pageof 73
Sort By:
Scientific Reports|October 9, 2021
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancerStanley I Gutiontov, William Tyler Turchan, Liam F Spurr, et al.
Nature Cancer|November 28, 2022
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockadeLiam F Spurr, Carlos A Martinez, Wenjun Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2018
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid TumorsJason J Luke, Jeffrey M Lemons, Theodore G Karrison, et al.
Nature Communications|May 6, 2018
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasisSean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Nature Communications|November 15, 2018
Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasisSean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I TrialJason J Luke, Benjamin E Onderdonk, Sandeep R Bhave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomasTanguy Y Seiwert, Zhixiang Zuo, Michaela K Keck, et al.
Radiation Research|October 12, 2020
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?Pataje G Prasanna, Gayle E Woloschak, Andrea L DiCarlo, et al.
Nature Communications|May 13, 2020
Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunitySangman M Kim, Jennifer R DeFazio, Sanjiv K Hyoju, et al.
Pageof 73

Showing results (711-720 of 727) with videos related to

Sort By:
Pageof 73
Scientific Reports|October 9, 2021
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancerStanley I Gutiontov, William Tyler Turchan, Liam F Spurr, et al.
Nature Cancer|November 28, 2022
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockadeLiam F Spurr, Carlos A Martinez, Wenjun Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2018
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid TumorsJason J Luke, Jeffrey M Lemons, Theodore G Karrison, et al.
Nature Communications|May 6, 2018
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasisSean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Nature Communications|November 15, 2018
Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasisSean P Pitroda, Nikolai N Khodarev, Lei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2021
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid TumorsCorey C Foster, Gini F Fleming, Theodore G Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2020
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I TrialJason J Luke, Benjamin E Onderdonk, Sandeep R Bhave, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2014
Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomasTanguy Y Seiwert, Zhixiang Zuo, Michaela K Keck, et al.
Radiation Research|October 12, 2020
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?Pataje G Prasanna, Gayle E Woloschak, Andrea L DiCarlo, et al.
Nature Communications|May 13, 2020
Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunitySangman M Kim, Jennifer R DeFazio, Sanjiv K Hyoju, et al.
Pageof 73